Chevron

U.S. judge sets trial in litigation against Syngenta alleging weed killer causes Parkinson’s disease

Print Email Share Tweet
Posted on by Carey Gillam

A federal judge appointed to coordinate proceedings for claims that Syngenta AG’s paraquat weed killers cause Parkinson’s disease said Wednesday she was setting a jury trial date for Nov. 15, 2022.

U.S. Judge Nancy Rosenstengel of the Southern District of Illinois issued the order in an initial hearing with lawyers from multiple firms who are representing people alleging their exposure to Syngenta’s popular herbicides caused them or family members to develop and suffer from the dreaded neurological disorder.

There are 157 cases pending in state and federal courts around the country, according to a June 22 court filing. The plaintiffs allege Syngenta was aware of the risks but failed to warn users.

Syngenta, which is owned by a Chinese chemical company, has denied the allegations.

Along with Syngenta, the defendants include Chevron Phillips Chemical Company LP, and Chevron USA, Inc. All have denied any liability.

Several scientific studies have linked paraquat to Parkinson’s, including a large study of U.S. farmers jointly overseen by multiple U.S. government agencies.  Farmers use paraquat in the production of many crops, including corn, soy and cotton. The Agricultural Health Study (AHS) said it found that “exposure to agricultural pesticides may increase a person’s risk of developing Parkinson’s disease.” In 2011, AHS researchers reported that “participants who used paraquat or rotenone were twice as likely to develop Parkinson’s disease as people who didn’t use these chemicals.”

A more recent paper from AHS researchers stated that “Extensive literature suggests an association between general pesticide use and Parkinson’s disease (PD). However, with few exceptions, little is known about associations between specific pesticides and PD.”

Parkinson’s is an incurable progressive nervous system disorder that limits a person’s ability to control movement, causing tremors, loss of balance and eventually often leaving victims bedridden and/or bound to a wheelchair. The disease is not necessarily fatal but typically becomes severely debilitating.

Dutch neurologist Bastiaan Bloem, who recently authored a book about Parkinson’s, blames widespread exposure to herbicides such as paraquat, along with other toxic chemicals used in agriculture and manufacturing, for the spread of the disease.

The case number for the multidistrict litigation in the U.S. District Court for the Southern District of Illinois is 3:21-md-03004-NJR

Some cases already settled

Even as more than 100 cases move forward, several are in the process of settling.

A “notice of settlement” was filed on June 18 in California, stating that the parties in 16 cases pending in that state had reached agreement on settlement terms.

Among the law firms involved in that settlement notice is the Missouri-based firm headed by lawyer Steve Tillery.

Tillery was scheduled to bring one of his cases, Hoffman V. Syngenta, to trial last month, and has accumulated thousands of pages of internal company documents through discovery. He had  threatened to introduce evidence that he said included internal company records showing Syngenta has known for decades that its product causes Parkinson’s Disease.

Tillery has refused to confirm settlement terms.

Paraquat Papers

Print Email Share Tweet
Posted on by Gary Ruskin

Multiple lawsuits are pending in the United States alleging the weedkilling chemical paraquat causes Parkinson’s disease, and the first case to go to trial over the allegations against Syngenta over paraquat and Parkinson’s was originally scheduled for April 12 but was rescheduled for May 10 in St. Clair County Circuit Court in Illinois and then was delayed again until June 1 and then was called off on May 28.  The parties reportedly settled the case.

A notice of settlement was filed June 18, 2021 for several paraquat cases. See this document.

There are dozens of lawsuits pending against Syngenta alleging the company’s paraquat products cause Parkinson’s Disease. The Hoffman case also names Chevron Phillips Chemical Co. and Growmark Inc. as defendants. Chevron distributed and sold Gramoxone paraquat product in the United States in an agreement with a Syngenta predecessor called Imperial Chemical Industries (ICI), which introduced paraquat-based Gramoxone in 1962. Under a license agreement, Chevron had the right to to manufacture, use, and sell paraquat formulations in the U.S.

Lawyers around the United States are advertising for plaintiffs, seeking to draw in thousands of people who’ve been exposed to paraquat and now suffer from Parkinson’s.

Some of  the most recently filed cases were brought in federal courts in California and Illinois. Among those cases are Rakoczy V. Syngenta,  Durbin V. Syngenta and Kearns V. Syngenta.

On April 7, 2021, the Fears Nachawati Texas-based law firm filed a motion with the U.S. Judicial Panel on Multidistrict Litigation in Washington, D.C., asking that pending paraquat lawsuits be consolidated for pretrial proceedings in the Northern District of California, the same federal court where Roundup litigation was consolidated. The case with the judicial panel is MDL No. 3004. The panel hearing on the matter was May 27 and on June 7, the panel approved the formation of the paraquat multidistrict litigation, assigning it to Judge  Nancy J. Rosenstengel in the Southern District of Illinois.

Additionally, a class action lawsuit was filed in federal court in Iowa on May 3. The suit seeks “equitable relief in the form of medical monitoring, including, but not limited to, the costs of diagnostic testing” for farmers and others exposed to paraquat who are allegedly at “increased risk” for Parkinson’s, according to the legal filing.

Several scientific studies have linked paraquat to Parkinson’s, including a large study of U.S. farmers jointly overseen by multiple U.S. government agencies.  Farmers use paraquat in the production of many crops, including corn, soy and cotton. The Agricultural Health Study (AHS) said it found that “exposure to agricultural pesticides may increase a person’s risk of developing Parkinson’s disease.” In 2011, AHS researchers reported that “participants who used paraquat or rotenone were twice as likely to develop Parkinson’s disease as people who didn’t use these chemicals.”

A more recent paper from AHS researchers stated that “Extensive literature suggests an association between general pesticide use and Parkinson’s disease (PD). However, with few exceptions, little is known about associations between specific pesticides and PD.”

Parkinson’s is an incurable progressive nervous system disorder that limits a person’s ability to control movement, causing tremors, loss of balance and eventually often leaving victims bedridden and/or bound to a wheelchair. The disease is not necessarily fatal but typically becomes severely debilitating.

Dutch neurologist Bastiaan Bloem, who recently authored a book about Parkinson’s, blames widespread exposure to herbicides such as paraquat, along with other toxic chemicals used in agriculture and manufacturing, for the spread of the disease.

Acutely Toxic 

Along with fears about links between paraquat and Parkinson’s, paraquat is also known to be an extremely acutely toxic chemical that can quickly kill people who ingest very small amounts. In Europe, the sale of paraquat has been banned since 2007, but in the United States the pesticide is sold as a “Restricted Use Pesticide” due to “acute toxicity.”

As part of discovery in the Parkinson’s litigation, lawyers have obtained internal records from Syngenta and its predecessor corporate entities dating back to the 1960s. Many of these documents are sealed, but some have started to come to light.

Those unsealed discovery documents, which include copies of letters, minutes of meetings, study summaries, and emails, are being made available on this page.

Most of the documents unsealed to date deal with corporate discussions about how to keep paraquat herbicides on the market despite its deadliness, through measures designed to reduce accidental poisonings. Specifically, many of the documents detail an internal corporate struggle over the addition of an emetic, a vomit-inducing agent, to paraquat products.  Today, all Syngenta paraquat-containing products include an emetic called “PP796.”  Liquid paraquat-containing formulations from Syngenta also include a stenching agent to produce a foul odor, and a blue dye to differentiate the dark-colored herbicide from tea or cola or other beverages.

EPA Review 

Paraquat is currently undergoing the EPA’s registration review process, and on Oct. 23, 2020, the agency  released a proposed interim decision (PID) for paraquat, which proposes mitigation measures to reduce human health and ecological risks identified in the agency’s 2019 draft human health and ecological risk assessments.

The EPA said that through collaboration with the National Toxicology Program at the National Institute of Environmental Health Sciences, the agency completed a “thorough review” of the scientific information on paraquat and Parkinson’s Disease and concluded that the weight of evidence was insufficient to link paraquat to Parkinson’s disease. The agency published this “Systematic Review of the Literature to Evaluate the Relationship between Paraquat Dichloride Exposure and Parkinson’s Disease.”

USRTK will add documents to this page as they become available.

Consolidation approved for lawsuits against Syngenta and Chevron over herbicide

Print Email Share Tweet
Posted on by Carey Gillam

A U.S. judicial panel has ordered the pretrial consolidation of dozens of lawsuits against Syngenta and Chevron over allegations that paraquat weed killer, which has been used widely around the world for more than 50 years, causes Parkinson’s disease.

The U.S. Judicial Panel on Multidistrict Litigation said that “to date, 77 actions and potential tag-along actions are pending in sixteen different districts,” and they all involve “common factual issues concerning the propensity of paraquat to cause Parkinson’s Disease.” The cases will include “complex scientific and regulatory issues,” the panel said.

“Centralization will eliminate duplicative discovery; avoid inconsistent pretrial rulings; and conserve the resources of the parties, their counsel and the judiciary,” the panel stated in its order.

The panel determined the cases will be transferred to the federal court in the Southern District of Illinois and assigned to U.S. Judge Nancy Rosenstengel for handling.

Lawyer Majed Nachawati, whose firm is among those representing hundreds of plaintiffs suing Syngenta and Chevron, applauded the decision, and said the litigation is “monumentally important.” It was Nachawati’s firm that requested the MDL.

Syngenta, a Swiss company owned by a larger Chinese chemical company, developed and markets the paraquat-based Gramoxone brand, while Chevron has been a distributor of Syngenta’s paraquat products in the United States.

The formation of the paraquat multidistrict litigation (MDL) underscores the legal threat Syngenta faces in the litigation.  An MDL was also formed for the lawsuits filed against Monsanto over allegations that its Roundup weed killers cause non-Hodgkin lymphoma; ultimately tens of thousands of people sued the company for such claims and Monsanto’s owner, Bayer AG, is now facing settlement payouts of more than $10 billion.

Syngenta said in a statement that it agrees with the decision to coordinate the various federal lawsuits before one judge.

“This will help the parties and the courts proceed in a timely and efficient way,” the company said.

Chevron did not respond to a request for comment.

Used since the ’60s

Paraquat has been used in the United States since 1964 as a tool to kill broadleaf weeds and grasses. Farmers often use paraquat before planting crops or before those crops emerge. It has long been known to be extremely dangerous to anyone who ingests even a small amount, and regulators have issued warnings and placed restrictions on its use because of poisoning risks.

The body of science showing links between Parkinson’s disease and paraquat is less clear, having evolved over time. The EPA does not currently confirm a causal link to Parkinson’s disease. But many scientists say the research showing causation is robust.

Several scientific studies have linked paraquat to Parkinson’s, including a large study of U.S. farmers jointly overseen by multiple U.S. government agencies.

The Agricultural Health Study (AHS), which is backed by numerous U.S. agencies and researchers, has found that “exposure to agricultural pesticides may increase a person’s risk of developing Parkinson’s disease.” And in 2011, AHS researchers reported that participants who used paraquat or another pesticide were “twice as likely to develop Parkinson’s disease” as people who were not exposed to those chemicals.

Syngenta maintains that newer and better research, including by AHS scientists, has discounted a tie between paraquat and Parkinson’s.

In addition to the cases brought on behalf of people suffering from Parkinson’s, additionally, a class action lawsuit was filed in federal court in Iowa on May 3 by a law firm representing people who fear they may get the disease in the future.

The suit seeks “equitable relief in the form of medical monitoring, including, but not limited to, the costs of diagnostic testing” for farmers and others exposed to paraquat who are allegedly at “increased risk” for Parkinson’s, according to the legal filing.

Settlement rumors

What was supposed to be the first trial over allegations that Syngenta’s paraquat causes Parkinson’s has been delayed multiple times and the parties may be nearing a settlement, according to sources close to the case.

The trial in the case of Hoffman V. Syngenta is pending in St. Clair County Circuit Court in Illinois and has had multiple trial dates set and then cancelled, the most recent earlier this month.

The lawyer for the plaintiffs in that case had pronounced publicly that he had internal Syngenta documents that would expose the company’s alleged knowledge of connections between paraquat and Parkinson’s.

But Syngenta steadfastly has denied any such evidence exists.

“Syngenta has great sympathy for the health issues faced by the plaintiffs and others suffering from the debilitating effects of Parkinson’s disease,” the company’s statement reads.  “We care deeply about the health and well-being of farmers and are dedicated to providing them safe and effective products. There is no credible evidence that Paraquat, which has been widely used for more than 55 years, causes Parkinson’s disease.  No peer reviewed study, including the largest study which involved 38,000 farmers, has ever concluded Paraquat causes Parkinson’s disease.  The EPA and other government authorities have extensively analyzed this issue and similarly found no evidence that Paraquat causes Parkinson’s disease. The facts simply do not support the Plaintiffs’ allegations, and we intend to defend this product and our legal position vigorously in court.”

Another delay for trial set to examine allegation that Syngenta weed killer causes Parkinson’s

Print Email Share Tweet
Posted on by Carey Gillam

A highly anticipated first-ever trial pitting a group of farmers against the global agricultural giant Syngenta AG over allegations that Syngenta’s paraquat weed killer causes Parkinson’s disease has been delayed again and may not take place at all, according to sources close to the case.

The trial in the case of Hoffman V. Syngenta was scheduled to start June 1 in St. Clair County Circuit Court in Illinois before Associate Judge Kevin Hoerner. Previously it was set to begin May 10, and prior to that it had a trial date in April.

The cancellation of the June 1 trial date came amid speculation that the parties are deep into settlement talks. No new trial date has yet been set, according to a St. Clair County Circuit Court clerk.

The plaintiffs in the case developed Parkinson’s after repeated exposure to paraquat products, specifically Syngenta’s widely used Gramoxone brand. Three of the original plaintiffs in the case have died, including plaintiff Thomas Hoffman.

The trial was to be livestreamed by Courtroom View Network, and plaintiffs’ attorney Steve Tillery had vowed to unveil decades of internal corporate documents he said would show Syngenta knew its paraquat-based weed killer causes Parkinson’s disease, a disorder that impacts nerve cells in the brain and  leads in advanced cases to severe physical debilitation and often dementia and death.

Tillery would not respond to a request for comment, and a Syngenta spokesman also declined to comment.

Also named as defendants in the case are Chevron Phillips Chemical Co., formed as a joint venture between Chevron USA and Phillips 66. Chevron helped distribute Syngenta’s products in the United States. Illinois agricultural cooperative Growmark is also a defendant for its role in supplying paraquat products.

There are currently at least 20 lawsuits filed in multiple state and federal courts across the country on behalf of plaintiffs who have been diagnosed with Parkinson’s and claim Syngenta’s paraquat weed killers are to blame.

The caseload is expected to grow rapidly, and on Thursday the U.S. Judicial Panel on Multidistrict Litigation heard arguments on a motion filed by the Texas-based law firm of Fears Nachawati asking that pending paraquat lawsuits be consolidated for pretrial proceedings in the Northern District of California, the same federal court where Roundup litigation was consolidated.

Additionally, a class action lawsuit was filed in federal court in Iowa on May 3. The suit seeks “equitable relief in the form of medical monitoring, including, but not limited to, the costs of diagnostic testing” for farmers and others exposed to paraquat who are allegedly at “increased risk” for Parkinson’s, according to the legal filing.

Several scientific studies have linked paraquat to Parkinson’s, including a large study of U.S. farmers jointly overseen by multiple U.S. government agencies.

Farmers use paraquat in the production of many crops, including corn, soy and cotton. The Agricultural Health Study (AHS) said it found that “exposure to agricultural pesticides may increase a person’s risk of developing Parkinson’s disease.” In 2011, AHS researchers reported that “participants who used paraquat or rotenone were twice as likely to develop Parkinson’s disease as people who didn’t use these chemicals.”

Syngenta argues that newer and more robust research, including by AHS scientists, has discounted a tie between paraquat and Parkinson’s.

Trial pitting farmers against Syngenta delayed until June

Print Email Share Tweet
Posted on by Carey Gillam

A highly anticipated first-ever trial pitting a group of farmers against the global agricultural giant Syngenta AG over allegations that Syngenta’s paraquat weed killer causes Parkinson’s disease has been delayed until June, the parties involved said on Saturday.

The trial was set to begin Monday, livestreamed by Courtroom View Network, but a continuance was ordered setting a new trial date for June 1. A spokesman for the plaintiffs’ legal team said the delay was not due to any settlement efforts, but due to “a combination of scheduling and Covid issues.”

The case is titled Hoffman V. Syngenta and is set for a bench trial in St. Clair County Circuit Court in Illinois before Associate Judge Kevin Hoerner.

The plaintiffs are farmers who developed Parkinson’s after repeated exposure to paraquat products, specifically Syngenta’s widely used Gramoxone brand, and the spouses of those farmers. Three of the original plaintiffs in the case have died, including plaintiff Thomas Hoffman.

Parkinson’s is a disorder that impacts nerve cells in the brain and  leads in advanced cases to severe physical debilitation and often dementia and death.

Experts in the study and treatment of Parkinson’s warn that the disease is on the rise. One such expert, Dutch neurologist Bastiaan Bloem, predicts the number of people suffering from Parkinson’s will double to more than 13 million in the next 20 years.

Bloem is one of many scientists who blame exposure to paraquat as among multiple risk factors for developing Parkinson’s.

Also named as defendants in the case are Chevron Phillips Chemical Co., formed as a joint venture between Chevron USA and Phillips 66. Chevron helped distribute Syngenta’s products in the United States. Illinois agricultural cooperative Growmark is also a defendant for its role in supplying paraquat products.

There are currently at least 20 lawsuits filed in multiple state and federal courts across the country on behalf of plaintiffs who have been diagnosed with Parkinson’s, and claim Syngenta’s paraquat weed killers are to blame.

Lawyer C. Calvin Warriner III, who is not involved in the Hoffman case but has other plaintiffs suing over the same issues, said he predicts “hundreds if not thousands of cases” will be filed in the next year because of “solid” scientific evidence linking paraquat to Parkinson’s.

Paraquat litigation grows, first trial set for May 10

Print Email Share Tweet
Posted on by Carey Gillam

Six more lawsuits alleging Syngenta’s weed killing pesticide paraquat causes Parkinson’s Disease were filed last week in Pennsylvania, California and Illinois, adding to more than a dozen similar lawsuits already filed in U.S. courts.

The lawsuits all allege that exposure to paraquat,  which is banned in more than 30 countries though not in the United States, causes the incurable and progressive Parkinson’s disorder that affects nerve cells in the brain, leading in advanced cases to severe physical debilitation and often dementia and death.

Many Parkinson’s experts say the disease can be caused by a range of factors, including exposure to pesticides such as paraquat, as well as other chemicals.

The first trial set to take place in the United States is to begin on May 10 in St. Clair County Circuit Court in Illinois. Missouri lawyer Steve Tillery  is representing the plaintiffs in Hoffman V. Syngenta and said he plans to introduce evidence that includes internal company records showing Syngenta has known for decades that its product causes Parkinson’s Disease.

The defendants in the Hoffman case, as well as the other cases filed, name the Swiss-based Syngenta and Chevron USA as defendants.

Both Chevron and Syngenta deny there is a connection between the disease and the weed killer.

Chevron distributed and sold paraquat products in the United States starting with an agreement with a Syngenta predecessor called Imperial Chemical Industries (ICI), which introduced a paraquat-based herbicide called Gramoxone in 1962. Under a license agreement, Chevron had the right to manufacture, use, and sell paraquat formulations in the U.S.

Syngenta says that its paraquat products have been approved as “safe and effective” for more than 50 years and it will “vigorously” defend the lawsuits. Syngenta is owned by China National Chemical Corporation, known as ChemChina.

The complaints were filed on April 30 by a team of law firms: DiCello Levitt Gutzler, Saltz Mongeluzzi & Bendesky, P.C. and  Searcy Denney.

Mark DiCello, one of the plaintiffs’ attorneys bringing the cases, said Chevron and Syngenta have “long known they were peddling this poison,” and that the science surrounding paraquat “is conclusively on the side of the plaintiffs.”

Jeffrey Goodman, another of the plaintiffs’ attorneys helping bring the litigation said the filings so far are but the “tip of the iceberg” of what he expects to expand into a major mass tort case.

“The manufacturers of paraquat knew for decades that their product was linked to Parkinson’s disease yet chose to hide this information from regulators and the public,” Goodman said.

The newly filed cases are:

The new cases join at least 14 lawsuits filed by eight different law firms in six different federal courts across the country.

Federal court rejects Syngenta’s bid to toss lawsuit over paraquat herbicide

Print Email Share Tweet
Posted on by Carey Gillam

A federal judge has denied Swiss chemical company Syngenta’s effort to throw out one of a growing number of lawsuits alleging the company’s weed killing products cause Parkinson’s Disease. The decision offers a boost for the expanding number of law firms and plaintiffs making similar claims.

In an April 12 ruling, U.S. District Judge John Ross in the Eastern District of Missouri denied a motion filed by Syngenta and co-defendant Chevron that sought to dismiss a lawsuit brought by married Missouri couple Henry and Tara Holyfield.

“We were pleased that the court denied the motions to dismiss,” said Steven Crick, an attorney with the firm of Humphrey, Farrington & McClain who is representing the Holyfields. “We are also confident that the defendants’ efforts to dismiss or derail the case will continue.”

The lawsuit alleges Henry Holyfield developed Parkinson’s, a debilitating and incurable progressive nervous system disorder, due to his exposure to paraquat in his work as a crop duster. The suit alleges that paraquat was distributed “without adequate instructions on safe use” and “without instructions or warnings that the paraquat was dangerous to health and life and caused disease.”

Syngenta manufacturers and distributes paraquat-based Gramoxone, a widely used weed killer popular with American farmers but banned in more than 30 countries because it is known to be acutely toxic. Syngenta acknowledges the dangers of accidental poisoning associated with paraquat, and its products carry strict warning labels about precautions needed for safe use.

But the company has denied the validity of scientific research that has found associations between paraquat exposure and Parkinson’s Disease.

Chevron gained sales and distribution rights for Gramoxone paraquat product in the United States in an agreement with a Syngenta predecessor called Imperial Chemical Industries (ICI), which introduced paraquat-based Gramoxone in 1962. Under a license agreement, Chevron was granted rights to manufacture, use, and sell paraquat formulations in the U.S.

In their motion to dismiss the case, Syngenta and Chevron argued that the Holyfield claims were preempted by federal law governing regulation of paraquat by the Environmental Protection Agency (EPA).

“Paraquat has been heavily regulated by the EPA for decades under the Federal Insecticide, Fungicide, and Rodenticide Act (FIFRA)…” the motion states. “Through decades of scrutiny, the EPA’s judgment continues to be that paraquat is safe for sale and use so long as EPA-prescribed precautions are taken and instructions are followed. To ensure uniformity, FIFRA prohibits states from imposing any labeling requirements “in addition to or different from” FIFRA’s requirements and EPA-approved labels… But that is exactly what the complaint seeks to do.”

Judge Ross said the argument was flawed. FIFRA states that registration approval by the EPA “does not
constitute an absolute defense” to claims that a product was “mislabeled,” he wrote in his decision. Moreover, a 2005 U.S. Supreme Court ruling in a case titled Bates v. Dow Agrosciences established that the EPA’s approval of a product does not rule out claims of a failure to warn brought under state law.

“This Court is aware of no case since Bates in which a court has declined jurisdiction over a FIFRA-related claim pursuant to the doctrine of primary jurisdiction,” the judge wrote in his ruling. “The results of the EPA’s review of paraquat, moreover, will not dictate the success or failure of Plaintiffs’ claims.”

There are currently at least 14 lawsuits filed by eight different law firms in six different federal courts across the country. The lawsuits are all filed on behalf of plaintiffs who have been diagnosed with the neurodegenerative disorder, and they all allege exposure to Syngenta’s paraquat caused their conditions. Several other cases making the same allegations are pending in state courts as well.

The American Council on Science and Health is a Corporate Front Group

Print Email Share Tweet
Posted on by Gary Ruskin

Updated in July 2019

The American Council on Science and Health (ACSH) calls itself a “pro-science consumer advocacy organization” and media outlets often quote the group as an independent science source; however, documents described in this fact sheet establish that ACSH is corporate front group that solicits money from tobacco, chemical, cosmetic, pharmaceutical and other companies in exchange for defending and promoting their products. The group does not disclose its funding.

Key documents:

  • Emails from 2015 released via discovery reveal that Monsanto funded ACSH and asked the group to help defend glyphosate.
  • Leaked financial documents from 2012 establish that ACSH solicits money from corporations for product defense campaigns. Donors include a wide array of companies and industry groups.
  • Emails from 2009 show that ACSH solicited $100,000 from Syngenta to write a paper and book about Syngenta’s pesticide atrazine. In 2011, ACSH released a book by Jon Entine similar to the project described in the email.
  • Syngenta and Monsanto have been regular contributors to ACSH over the years, the emails show.

Monsanto funds ACSH to defend Monsanto products

Emails released in April 2019 reveal that Monsanto agreed to fund ACSH in 2015 and asked the group to help defend glyphosate from cancer concerns raised by the International Agency for Research. ACSH agreed to do so, and later attacked the cancer report as a “scientific fraud.” The emails illuminate ACSH’s reliance on corporate funding and efforts to please its funders. ACSH’s former acting director Gil Ross (who spent time in jail for Medicaid fraud) wrote to a Monsanto executive, “Each and every day, we work hard to prove our worth to companies such as Monsanto.” Ross wrote:

Emails also show that Monsanto executives paid ACSH despite their discomfort with the group. Monsanto’s senior science lead Daniel Goldstein championed ACSH to his colleagues, and sent them links to 53 ACSH articles, two books and a pesticide review he described as as “EXTREMELY USEFUL.” Goldstein wrote:

Key player in Monsanto’s propaganda network

An award-winning investigation by Le Monde into Monsanto’s “war on science” to defend glyphosate named the American Council on Science and Health among the “well known propaganda websites” that played a key role in attacking the scientists who raised cancer concerns. In May 2017, plaintiffs’ attorneys suing Monsanto over glyphosate cancer concerns stated in a brief: “Monsanto quietly funnels money to ‘think tanks’ such as the ‘Genetic Literacy Project’ and the ‘American Council on Science and Health,’ organizations intended to shame scientists and highlight information helpful to Monsanto and other chemical producers.”

Emails obtained by U.S. Right to Know reveal that Monsanto initially chose ACSH to publish a series of pro-GMO papers that were assigned to professors by Monsanto and “merchandized” by a PR firm to heavily promote them as independent. Monsanto executive Eric Sachs wrote to the professors: “To ensure that the papers have the greatest impact, the American Council for Science and Health is partnering with CMA Consulting to drive the project. The completed policy briefs will be offered on the ACSH website … CMA and ACSH also will merchandize the policy briefs, including the development of media specific materials, such as op-eds, blog postings, speaking engagements, events, webinars, etc.” The papers were eventually published by Genetic Literacy Project with no disclosure of Monsanto’s role.

In a report from the U.S. House of Representatives, congressional investigators stated that Monsanto uses “industry trade groups, such as CropLife and industry front groups, such as Genetic Literacy Project and Academics Review as platforms of support for industry spokespersons.”

Leaked ACSH docs reveal corporate-defense funding strategy

A leaked 2012 ACSH financial summary reported by Mother Jones revealed that ACSH has received funding from a large number of corporations and industry groups with a financial stake in the science messaging ACSH promotes — and showed how ACSH solicits corporate donations for quid pro quo product-defense campaigns. For example, the document outlines:

  • Plans to pitch the Vinyl Institute which “previously supported chlorine and health report”
  • Plans to pitch food companies for a messaging campaign to oppose GMO labeling
  • Plans to pitch cosmetic companies to counter “reformulation pressures” from the Campaign for Safe Cosmetics
  • Efforts to court tobacco and e-cigarette companies

Mother Jones reported, “ACSH’s donors and the potential backers the group has been targeting comprise a who’s-who of energy, agriculture, cosmetics, food, soda, chemical, pharmaceutical, and tobacco corporations.” Funding details:

  • ACSH donors in the second half of 2012 included Chevron, Coca-Cola, the Bristol Myers Squibb Foundation, Dr. Pepper/Snapple, Bayer Cropscience, Procter and Gamble, Syngenta, 3M, McDonald’s, and tobacco conglomerate Altria. ACSH also pursued financial support from Pepsi, Monsanto, British American Tobacco, DowAgro, ExxonMobil Foundation, Philip Morris International, Reynolds American, the Koch family-controlled Claude R. Lambe Foundation, the Dow-linked Gerstacker Foundation, the Bradley Foundation and Searle Freedom Trust.
  • Reynolds American and Phillip Morris International were the two largest donors listed in the documents.

Syngenta funding, Syngenta defense

In 2011, ACSH published a book about “chemophobia” written by Jon Entine, who is now the executive director of the Genetic Literacy Project, another front group that works with Monsanto. Entine’s ACSH book defended atrazine, a pesticide manufactured by Syngenta, which was funding ACSH.

A 2012 Mother Jones article describes the circumstances leading up to the book. The article by Tom Philpott, based in part on internal company documents obtained by the Center for Media and Democracy, describes Syngenta’s PR efforts to get third-party allies to spin media coverage of atrazine.

In one email from 2009, ACSH staff asked Syngenta for an additional $100,000 – “separate and distinct from general operating support Syngenta has been so generously providing over the years” – to produce an atrazine-friendly paper and “consumer-friendly booklet” to help educate media and scientists.

Email from ASCH staffer Gil Ross to Syngenta about proposed atrazine project:

A year and a half later, ACSH published Entine’s book with a press release that sounds similar to the project Ross described in his solicitation email to Syngenta: “The American Council on Science and Health is pleased to announce a new book and companion friendly, abbreviated position paper” in response to the “irrational fear of chemicals.” Author Jon Entine denied any relationship with Syngenta and told Philpott he had “no idea” Syngenta was funding ACSH.

ACSH personnel

  • ACSH’s longtime “Medical/Executive Director” Dr. Gilbert Ross was convicted in a scheme to defraud the Medicaid system prior to joining ACSH. See court documents about Dr. Ross’ multiple fraud convictions and sentencing, and article in Mother Jones “Paging Dr. Ross” (2005). Dr. Ross was found to be a “highly untrustworthy individual” by a judge who sustained the exclusion of Dr. Ross from Medicaid for 10 years (see additional references and court document).
  • In June 2015, Hank Campbell took over ACSH leadership from acting president (and convicted felon) Dr. Gilbert Ross. Campbell worked for software development companies before starting the website Science 2.0 in 2006. In his 2012 book with Alex Berezow, “Science Left Behind: Feel Good Fallacies and the Rise of the Anti Science Left,” Campbell describes his background: “six years ago… I decided I wanted to write science on the Internet … with nothing but enthusiasm and a concept, I approached world famous people about helping me reshape how science could be done, and they did it for free.” Campbell left suddenly under unknown circumstances in December 2018. Read more about Campbell here.
  • Campbell’s book co-author, Alex Berezow, is now vice president of scientific affairs at ACSH.  He is a founding editor of Real Clear Science and is on the USA Today editorial board of contributors but USA Today does not disclose Berezow’s ACSH affiliation or ACSH’s corporate funding despite repeated complaints (more info below).

Leaders and advisors: tobacco ties and climate science denial  

The ACSH board of trustees includes Fred L. Smith Jr., founder of the Competitive Enterprises Institute, a leading promoter of climate science denial and a group that has received millions of dollars from Exxon Mobile and dark money funding vehicle Donors Trust.  Smith and CEI also have a history of fighting against tobacco regulations and soliciting money from the tobacco industry, according to documents from the UCSF Truth Tobacco Industry Documents archive. 

James Enstrom and Geoffrey Kabat, two epidemiologists who took money from tobacco companies and wrote studies defending tobacco products, also have ACSH ties. Dr. Enstrom is a member of the ACSH board of trustees and Dr. Kabat serves on the “health board of scientific advisors“. Both scientists have “long standing financial and other working relationships with the tobacco industry,” according to a paper in BMJ Tobacco Control.

In a widely cited 2003 paper in BMJ, Kabat and Enstrom concluded that secondhand smoke does not increase the risk of lung cancer and heart disease. The study was sponsored in part by the Center for Indoor Air Research (CIAR), a tobacco industry group. Although that funding was disclosed, a follow-up analysis in BMJ Tobacco Control found that the disclosures by Enstrom and Kabat “did not provide the reader with a full picture of the tobacco industry’s involvement with the study authors.” The paper details numerous financial ties between Enstrom and the tobacco industry.

Enstrom countered these claims in a 2007 article in Epidemiological Perspectives and Innovation, arguing that his funding and competing interests were clearly and accurately described in the 2003 BMJ paper, and that tobacco industry funding did not impact his research. “To date, no impropriety, bias or omission has been identified in the review process and no error in the results has been identified in the paper,” Enstrom said.

Emails from 2014 feature Dr. Enstrom discussing with famous climate science denier Fred Singer ideas to attack and discredit two scientists who were involved in the film “Merchants of Doubt: How a Handful of Scientists Obscured the Truth on Issues from Tobacco Smoke to Global Warming,” and whether to try to stop the release of the film with a lawsuit. For more information, see DeSmog blog, “Tobacco Gun for Hire James Enstrom, Willie Soon and the Climate Deniers Attack on Merchants of Doubt” (March 2015).

Dr. Kabat is also on the board of directors of the parent organization of the Genetic Literacy Project, a front group that works with Monsanto on PR projects while claiming to be independent. Read more about his work in our fact sheet, Geoffrey Kabat’s Ties to Tobacco and Chemical Industry Groups

Incorrect statements about science 

American Council on Science and Health has claimed:

  • “There is no evidence that exposure to secondhand smoke involves heart attacks or cardiac arrest.” Winston-Salem Journal, 2012
  • “there is no scientific consensus concerning global warming.” ACSH, 1998 (Greenpeace has described ACSH a “Koch Industries climate denial front group”)
  • fracking “doesn’t pollute water or air.” Daily Caller, 2013
  • “There has never been a case of ill health linked to the regulated, approved use of pesticides in this country.” Tobacco Documents Library, UCSF, The Advancement of Sound Science Coalition document page 9, 1995
  • “There is no evidence that BPA [bisphenol A] in consumer products of any type, including cash register receipts, are harmful to health.” ACSH, 2012
  • exposure to mercury, a potent neurotoxin, “in conventional seafood causes no harm in humans.” ACSH, 2010.

Recent ACSH messaging continues in the same theme, denying risk from products that are important to the chemical, tobacco and other industries, and making frequent attacks on scientists, journalists and others who raise concerns.

  • A 2016 “top junk science” post by ACSH denies that chemicals can cause endocrine disruption; defends e-cigarettes, vaping and soda; and attacks journalists and the Journal of the American Medical Association.

USA Today gives ACSH a platform 

USA Today continues to publish columns by ACSH staffers Hank Campbell and Alex Berezow without disclosing their funding ties to corporations whose interests they defend. In February 2017, 30 health, environmental, labor and public interest groups wrote to the editors of USA Today asking the paper to stop providing a platform of legitimacy to ACSH or at least provide full disclosures about who funds the group.

The letter states:

  • “We are writing to express our concern that USA Today continues to publish columns written by members of the American Council on Science and Health (ACSH), a corporate-funded group with a long history of promoting corporate agendas that are at odds with mainstream science. USA Today should not be helping this group promote its false identity as a credible, independent source on science. Your readers deserve accurate information about what and whom this group represents, as they reflect on the content of the columns.”
  • “These are no idle allegations. Many of the undersigned health, environmental, labor and public interest groups have been tracking ACSH’s work over the years. We have documented instances in which the group has worked to undermine climate change science, and deny the health threats associated with various products, including second-hand smoke, fracking, pesticides and industrial chemicals – all without being transparent about its corporate backers.”
  • We note that financial documents obtained by Mother Jones show that ACSH has received funding from tobacco, chemical, pharmaceutical and oil corporations. Public interest groups have reported that ACSH received funding from the Koch Foundations between 2005-2011, and released internal documents showing that ACSH solicited $100,000 from Syngenta in 2009 to write favorably about its product atrazine – a donation that was to be “separate and distinct from general operating support Syngenta has been so generously providing over the years.”
  • “At a time when the public is questioning the legitimacy of the news media, we believe it is vital for publications such as USA Today to follow the highest standards of journalistic ethics and serve the public with as much truth and transparency as possible. We respectfully ask you to refrain from publishing further columns authored by members of the American Council on Science and Health, or at the very least require that the individuals identify the organization accurately as a corporate-funded advocacy group.”

As of December 2017, USA Today editorial page editor Bill Sternberg has declined to stop publishing ACSH columns and the paper has repeatedly provided inaccurate or incomplete disclosures for the columns, and failed to notify its readers about ACSH’s funding from corporations whose agenda they promote.